Libo Pharma is dedicated to developing novel cancer therapeutics to improve and extend the lives of patients who are impacted by cancer.
Patients are our guiding force. Their perseverance and resilience inspire us and fortifies our mission.

As we advance our investigational therapies and strive to improve outcomes for patients living with cancer, we understand the critical need to gain insights from patients, their families and patient advocacy leaders.

We have a deep appreciation for advocacy groups who are on the frontlines providing support to patients and families coping with the challenges of a cancer diagnosis. We support patient-focused groups aligned with our disease areas of focus, including hematology, liver cancer and numerous other solid tumors.